Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CRISPR Therapeutics AG CRSP

CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this... see more

NDAQ:CRSP - Post Discussion

View:
Post by phred7 on Dec 10, 2020 12:56am

regrets

I have been following this and 2 other CRISPR stocks for over 4 years... wow  did I make a mistake. I did not buy. This is a health care  bite me stock.  I wish I had the 20/20 when the stock was $30 and i wish had the hevos... sadly no. This  is this a $1000 stock. med stock is ripe. Help me\ please comment. thanks
Comment by foofadooo on Aug 19, 2021 7:25am
IMHO.....it's not to late there will br many growth stocks springboard off CRSPR....CRBU... is a good example... foof
Comment by CreatingApe on May 08, 2024 7:01pm
Lol if you think it's a 1000 dollar stock it's definitely not too late. 52.22 at close today...